Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:39 pm Sale |
2023-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP |
Armistice Capital, LLC | 723,104 4.990% |
-156,896 (-17.83%) |
Filing History |
| 2023-02-14 11:59 am Purchase |
2022-12-31 | 13G | Aridis Pharmaceuticals, Inc. ARDS |
Armistice Capital, LLC | 2,997,111 9.990% |
2,997,111 (New Position) |
Filing History |
| 2023-02-14 11:52 am Purchase |
2022-12-31 | 13G | Acurx Pharmaceuticals, Inc. ACXP |
Armistice Capital, LLC | 880,000 7.590% |
880,000 (New Position) |
Filing History |
| 2021-07-06 4:21 pm Purchase |
2021-06-23 | 13D | Acurx Pharmaceuticals, Inc. ACXP |
LUCI DAVID P | 1,351,106 13.200% |
1,351,106 (New Position) |
Filing History |
| 2021-07-06 4:20 pm Purchase |
2021-06-23 | 13D | Acurx Pharmaceuticals, Inc. ACXP |
DELUCCIA ROBERT J | 1,327,774 13.000% |
1,327,774 (New Position) |
Filing History |